Larvol Delta - CERo-Therapeutics-Progresses-Phase-1-CER1236-AML-Trial-with-Dosing-of-Third-Patient-in-Initial-Dose-Cohort

CER-1236 - CERo Therap

https://www.globenewswire.com/news-release/2025/09/22/3153987/0/en/cero-therapeutics-progresses-phase-1-cer-1236-aml-trial-with-dosing-of-third-patient-in-initial-dose-cohort.html

Sep 22, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next